GCM
Graham Capital Management’s Boston Scientific BSX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.3M | Buy |
180,075
+124,287
| +223% | +$13.3M | 0.29% | 25 |
|
|
2025
Q1 | $5.63M | Buy |
55,788
+53,177
| +2,037% | +$5.36M | 0.1% | 101 |
|
|
2024
Q4 | $233K | Sell |
2,611
-161,675
| -98% | -$14.4M | ﹤0.01% | 1001 |
|
|
2024
Q3 | $13.8M | Sell |
164,286
-14,850
| -8% | -$1.24M | 0.24% | 40 |
|
|
2024
Q2 | $13.8M | Buy |
+179,136
| New | +$13.8M | 0.3% | 30 |
|
|
2022
Q3 | – | Sell |
-49,731
| Closed | -$1.85M | – | 1068 |
|
|
2022
Q2 | $1.85M | Buy |
49,731
+41,026
| +471% | +$1.53M | 0.08% | 217 |
|
|
2022
Q1 | $385K | Buy |
+8,705
| New | +$385K | 0.01% | 639 |
|